Study shows detrimental impact of Long Covid on the education and lives of children and young people
20 September 2023
New research from the Nuffield Department of Primary Care Health Sciences, University of Oxford, and the universities of Stirling and Aberdeen, funded by the National Institute for Health and Care Research (NIHR), highlights the profound effect Long Covid can have on children and young people’s school experience and wider lives.
15 February 2023
People with blood cancers are among the most clinically vulnerable individuals to COVID-19 in the UK, and a new analysis of over 12 million patient health records has revealed inequalities in COVID-19 vaccine uptake among this group.
Clinician-patient communication about emergency aerial medical evacuation in case of infectious disease
1 February 2023
New research from the University of Oxford, published today in the Journal of Travel Medicine, has developed a simple six-step check list clinicians can use to improve communication, decision making and planning about the possibility and practicalities of Aerial Medical Evacuation (AME).
24 January 2023
Recently, Professor Chris Butler addressed the United Nations regarding the PANORAMIC Trial and the assistance of BAPS UK & Europe.
PANORAMIC trial finds molnupiravir does not reduce COVID-19 hospitalisation/deaths in vaccinated people at high risk
22 December 2022
Researchers from the University of Oxford have today released findings from a clinical trial investigating the effectiveness of the antiviral treatment molnupiravir against COVID-19 – the first treatment tested in the ongoing PANORAMIC trial.
Study reveals association between diagnosis of a neuropsychiatric condition and severe outcome from COVID-19 infection, and other severe acute respiratory infections
14 November 2022
New research from the University of Oxford has shown an increased risk of severe illness and death from both COVID-19 and other severe respiratory infections, such as influenza and pneumonia, among people with a pre-existing mental health condition.
14 November 2022
World Diabetes Day gives us an opportunity to reflect on, and recognise, all the great research being done across the Nuffield Department of Primary Care Health Sciences and Centre for Evidence-Based Medicine (CEBM), to review the evidence on COVID-19 and diabetes.
COVID-19 vaccine protects people of all body weights from hospitalisation and death, a study of 9 million adults in England finds
1 July 2022
Two doses of the COVID-19 vaccine are effective against severe disease for people who are underweight, overweight, or who have obesity, finds new research published in The Lancet Diabetes and Endocrinology, led by researchers at the University of Oxford.
Congratulations to FHS student, Harrison France, on receiving 1st place in IUPHAR Student Research Poster Competition 2022
22 April 2022
Final Honours student, Harrison France, from the Nuffield Department of Primary Care Health Science and the Centre for Evidence-Based Medicine, has recently been awarded 1st place in the the IUPHAR (International Union of Basic and Clinical Pharmacology) Student Research Poster Competition 2022 by the British Pharmacological Society, for his research on preventable deaths involving medicines.
13 April 2022
Congratulations to the amazing team of research nurses working in the Primary Care Clinical Trials Unit who have been shortlisted as finalists in the Oxford University Hospitals NHS Foundation Trust Staff Recognition Awards 2021.
12 April 2022
From today, the antiviral treatment Paxlovid has been included in the national PANORAMIC study, the UK’s fastest ever recruiting clinical trial of its kind, run by the Nuffield Department of Primary Care Health Sciences and supported by the National Institute for Health and Care research (NIHR).
4 April 2022
10,000 people have joined the PRINCIPLE Trial over the last two years and we want to say a big ‘Thank You’ to them all for their amazing contribution to testing treatments for COVID-19 in the community.
31 March 2022
The world’s largest study of community-based treatments for acute COVID-19 has reached a world-first, historic milestone: over twenty thousand participants from across the UK have now taken part in the PANORAMIC trial.
16 December 2021
Led by the University of Oxford, a team of UK-based researchers have today reported results of the largest ever study to compare the risks of cardiovascular events, such as myocarditis, pericarditis, and cardiac arrhythmia, between different vaccines and COVID-19 infection, and the first to investigate the association between cardiac events and the Oxford-AstraZeneca vaccine.
8 December 2021
Researchers from the University of Oxford have today started recruiting participants for a first-of-its-kind clinical trial to test novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 and those who are at higher risk of complications – partnering with the National Institute for Health Research (NIHR) and working with colleagues in several UK universities, and the NHS UK-wide.
Department Researchers work highlighted at NCRI festival: Fewer cases of children’s cancer picked up during COVID pandemic
12 November 2021
A study of cancer in children and young adults in England has found that fewer patients were diagnosed during the COVID-19 pandemic. The research, presented at the NCRI Festival, also shows that children who were diagnosed with cancer during the first wave of the pandemic were more likely to have been admitted to intensive care prior to their diagnosis.
PCR cycle threshold may be key to predicting infectiousness of people with asymptomatic and pre-symptomatic COVID-19, suggests new review.
1 November 2021
An international team of researchers, led from Centre for Evidence-based Medicine based in the Nuffield Department of Primary Care Health Sciences, University of Oxford, and funded by the World Health Organization and the National Institute for Health Research School for Primary Care Research, have today announced the findings from the most complete analysis of high-quality covid transmission studies in asymptomatic and pre-symptomatic people to date.